nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM2—type 1 diabetes mellitus	0.88	1	CbGaD
Darifenacin—Depressed mood—Ramipril—type 1 diabetes mellitus	0.0037	0.0958	CcSEcCtD
Darifenacin—Cough increased—Ramipril—type 1 diabetes mellitus	0.00181	0.0468	CcSEcCtD
Darifenacin—Trospium—CHRM2—type 1 diabetes mellitus	0.00159	0.39	CrCbGaD
Darifenacin—Mepenzolate—CHRM2—type 1 diabetes mellitus	0.00132	0.325	CrCbGaD
Darifenacin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00122	0.0317	CcSEcCtD
Darifenacin—Diphenidol—CHRM2—type 1 diabetes mellitus	0.00116	0.285	CrCbGaD
Darifenacin—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00108	0.0281	CcSEcCtD
Darifenacin—Influenza—Ramipril—type 1 diabetes mellitus	0.00104	0.0269	CcSEcCtD
Darifenacin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000998	0.0259	CcSEcCtD
Darifenacin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000955	0.0248	CcSEcCtD
Darifenacin—Weight increased—Ramipril—type 1 diabetes mellitus	0.000944	0.0245	CcSEcCtD
Darifenacin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000902	0.0234	CcSEcCtD
Darifenacin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000899	0.0233	CcSEcCtD
Darifenacin—Sweating—Ramipril—type 1 diabetes mellitus	0.000887	0.023	CcSEcCtD
Darifenacin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000868	0.0225	CcSEcCtD
Darifenacin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000818	0.0212	CcSEcCtD
Darifenacin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.0008	0.0207	CcSEcCtD
Darifenacin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000785	0.0203	CcSEcCtD
Darifenacin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000748	0.0194	CcSEcCtD
Darifenacin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000727	0.0189	CcSEcCtD
Darifenacin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000708	0.0183	CcSEcCtD
Darifenacin—Angioedema—Ramipril—type 1 diabetes mellitus	0.00066	0.0171	CcSEcCtD
Darifenacin—Syncope—Ramipril—type 1 diabetes mellitus	0.000648	0.0168	CcSEcCtD
Darifenacin—Palpitations—Ramipril—type 1 diabetes mellitus	0.000639	0.0166	CcSEcCtD
Darifenacin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000635	0.0165	CcSEcCtD
Darifenacin—Cough—Ramipril—type 1 diabetes mellitus	0.000631	0.0163	CcSEcCtD
Darifenacin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000615	0.0159	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000611	0.0158	CcSEcCtD
Darifenacin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000602	0.0156	CcSEcCtD
Darifenacin—Confusional state—Ramipril—type 1 diabetes mellitus	0.000595	0.0154	CcSEcCtD
Darifenacin—Oedema—Ramipril—type 1 diabetes mellitus	0.00059	0.0153	CcSEcCtD
Darifenacin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00059	0.0153	CcSEcCtD
Darifenacin—Shock—Ramipril—type 1 diabetes mellitus	0.00058	0.015	CcSEcCtD
Darifenacin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000579	0.015	CcSEcCtD
Darifenacin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000576	0.0149	CcSEcCtD
Darifenacin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000573	0.0149	CcSEcCtD
Darifenacin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00057	0.0148	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000537	0.0139	CcSEcCtD
Darifenacin—Insomnia—Ramipril—type 1 diabetes mellitus	0.000534	0.0138	CcSEcCtD
Darifenacin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000526	0.0136	CcSEcCtD
Darifenacin—Somnolence—Ramipril—type 1 diabetes mellitus	0.000524	0.0136	CcSEcCtD
Darifenacin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000519	0.0135	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000509	0.0132	CcSEcCtD
Darifenacin—Constipation—Ramipril—type 1 diabetes mellitus	0.000504	0.0131	CcSEcCtD
Darifenacin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000486	0.0126	CcSEcCtD
Darifenacin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000482	0.0125	CcSEcCtD
Darifenacin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000466	0.0121	CcSEcCtD
Darifenacin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000435	0.0113	CcSEcCtD
Darifenacin—Asthenia—Ramipril—type 1 diabetes mellitus	0.000423	0.011	CcSEcCtD
Darifenacin—Pruritus—Ramipril—type 1 diabetes mellitus	0.000417	0.0108	CcSEcCtD
Darifenacin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000404	0.0105	CcSEcCtD
Darifenacin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00039	0.0101	CcSEcCtD
Darifenacin—Vomiting—Ramipril—type 1 diabetes mellitus	0.000375	0.00972	CcSEcCtD
Darifenacin—Rash—Ramipril—type 1 diabetes mellitus	0.000372	0.00964	CcSEcCtD
Darifenacin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000372	0.00963	CcSEcCtD
Darifenacin—Headache—Ramipril—type 1 diabetes mellitus	0.00037	0.00958	CcSEcCtD
Darifenacin—Nausea—Ramipril—type 1 diabetes mellitus	0.00035	0.00908	CcSEcCtD
Darifenacin—CHRM4—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.94e-05	0.00051	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.94e-05	0.00051	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—SST—type 1 diabetes mellitus	3.93e-05	0.00051	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.93e-05	0.000509	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.92e-05	0.000508	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.92e-05	0.000507	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—SST—type 1 diabetes mellitus	3.9e-05	0.000505	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	3.88e-05	0.000503	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.88e-05	0.000502	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.87e-05	0.000502	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	3.87e-05	0.000502	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.86e-05	0.0005	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.82e-05	0.000495	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	3.81e-05	0.000493	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.8e-05	0.000492	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.77e-05	0.000489	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.77e-05	0.000489	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.77e-05	0.000489	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.73e-05	0.000483	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	3.72e-05	0.000482	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.72e-05	0.000482	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.72e-05	0.000482	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.68e-05	0.000477	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.62e-05	0.000469	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.61e-05	0.000468	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.61e-05	0.000468	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.61e-05	0.000468	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.6e-05	0.000466	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.58e-05	0.000463	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.57e-05	0.000462	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.56e-05	0.000461	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.52e-05	0.000456	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.51e-05	0.000454	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	3.5e-05	0.000453	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.47e-05	0.00045	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SST—type 1 diabetes mellitus	3.46e-05	0.000448	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.44e-05	0.000446	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.4e-05	0.000441	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GAL—type 1 diabetes mellitus	3.39e-05	0.000439	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.39e-05	0.000439	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ITPR3—type 1 diabetes mellitus	3.38e-05	0.000438	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.38e-05	0.000437	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.36e-05	0.000436	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.36e-05	0.000436	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GAL—type 1 diabetes mellitus	3.36e-05	0.000435	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.35e-05	0.000434	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.35e-05	0.000434	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.34e-05	0.000433	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.32e-05	0.00043	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.32e-05	0.00043	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SST—type 1 diabetes mellitus	3.31e-05	0.000429	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.3e-05	0.000427	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.29e-05	0.000426	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.28e-05	0.000425	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.28e-05	0.000425	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.27e-05	0.000423	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.25e-05	0.000421	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.24e-05	0.000419	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—HBA1—type 1 diabetes mellitus	3.19e-05	0.000413	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOC3—type 1 diabetes mellitus	3.17e-05	0.00041	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.16e-05	0.00041	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.15e-05	0.000408	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	3.15e-05	0.000408	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTT1—type 1 diabetes mellitus	3.11e-05	0.000403	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GCG—type 1 diabetes mellitus	3.08e-05	0.000399	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	3.03e-05	0.000393	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.99e-05	0.000387	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.98e-05	0.000385	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.97e-05	0.000384	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GCG—type 1 diabetes mellitus	2.95e-05	0.000382	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.88e-05	0.000373	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.87e-05	0.000372	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.84e-05	0.000368	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.84e-05	0.000368	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.83e-05	0.000367	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.8e-05	0.000363	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.8e-05	0.000363	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.79e-05	0.000362	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.76e-05	0.000358	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.76e-05	0.000358	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.76e-05	0.000357	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.75e-05	0.000356	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.75e-05	0.000356	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.72e-05	0.000353	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.67e-05	0.000346	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.66e-05	0.000345	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.66e-05	0.000344	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.66e-05	0.000344	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.65e-05	0.000343	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.65e-05	0.000343	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.64e-05	0.000342	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.62e-05	0.00034	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.62e-05	0.00034	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.62e-05	0.000339	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.61e-05	0.000338	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.54e-05	0.000329	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.54e-05	0.000328	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD86—type 1 diabetes mellitus	2.51e-05	0.000325	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.51e-05	0.000325	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.51e-05	0.000325	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.51e-05	0.000325	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.5e-05	0.000324	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.5e-05	0.000324	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	2.48e-05	0.000321	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.47e-05	0.000321	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.43e-05	0.000315	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	2.41e-05	0.000312	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.4e-05	0.000311	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.4e-05	0.000311	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.38e-05	0.000309	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	2.33e-05	0.000302	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	2.32e-05	0.000301	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.32e-05	0.000301	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.31e-05	0.0003	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	2.3e-05	0.000298	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.3e-05	0.000298	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.29e-05	0.000297	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.29e-05	0.000296	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.28e-05	0.000296	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.27e-05	0.000293	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.23e-05	0.000289	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.2e-05	0.000284	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.18e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.17e-05	0.000281	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.13e-05	0.000276	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.1e-05	0.000272	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	2.1e-05	0.000272	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.09e-05	0.00027	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.08e-05	0.000269	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	2.07e-05	0.000268	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	2.05e-05	0.000266	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	2.02e-05	0.000262	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2e-05	0.000259	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.99e-05	0.000258	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.98e-05	0.000257	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.97e-05	0.000256	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.94e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.94e-05	0.000251	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.94e-05	0.000251	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.93e-05	0.00025	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.92e-05	0.000248	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.91e-05	0.000248	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.9e-05	0.000247	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.89e-05	0.000245	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.86e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.83e-05	0.000237	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.77e-05	0.000229	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.76e-05	0.000228	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.76e-05	0.000228	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.76e-05	0.000227	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.75e-05	0.000227	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.74e-05	0.000226	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.74e-05	0.000225	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	1.73e-05	0.000224	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.69e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.69e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.68e-05	0.000217	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.67e-05	0.000217	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.67e-05	0.000216	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	1.66e-05	0.000215	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.62e-05	0.00021	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.61e-05	0.000209	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.61e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.6e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.6e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.6e-05	0.000207	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.6e-05	0.000207	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.59e-05	0.000206	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.57e-05	0.000203	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.55e-05	0.0002	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.53e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.52e-05	0.000197	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.52e-05	0.000197	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.51e-05	0.000195	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.5e-05	0.000195	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.5e-05	0.000194	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.48e-05	0.000192	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.48e-05	0.000192	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.48e-05	0.000192	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.48e-05	0.000192	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.48e-05	0.000191	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.47e-05	0.00019	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.46e-05	0.00019	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.46e-05	0.000189	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.45e-05	0.000188	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.45e-05	0.000188	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—INS—type 1 diabetes mellitus	1.39e-05	0.00018	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.32e-05	0.000171	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.29e-05	0.000167	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.29e-05	0.000167	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.28e-05	0.000166	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.25e-05	0.000162	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.25e-05	0.000161	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.24e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.24e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.23e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	1.23e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.23e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.23e-05	0.000159	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	1.22e-05	0.000158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.22e-05	0.000158	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.22e-05	0.000157	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	1.17e-05	0.000151	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	1.16e-05	0.000151	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	1.15e-05	0.000149	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.13e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.13e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.12e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.12e-05	0.000145	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.12e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.11e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.08e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.04e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.04e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.04e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.03e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.02e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.02e-05	0.000132	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.01e-05	0.000131	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.85e-06	0.000128	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	9.69e-06	0.000125	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.43e-06	0.000122	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.69e-06	0.000113	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.68e-06	0.000112	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.67e-06	0.000112	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	8.65e-06	0.000112	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.64e-06	0.000112	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.61e-06	0.000112	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.58e-06	0.000111	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	8.57e-06	0.000111	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.53e-06	0.00011	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	8.32e-06	0.000108	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	8.2e-06	0.000106	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	7.63e-06	9.89e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	7.57e-06	9.8e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.31e-06	9.46e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	7.3e-06	9.46e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.28e-06	9.43e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	7.25e-06	9.39e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.21e-06	9.34e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.64e-06	8.6e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.62e-06	8.57e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.55e-06	8.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	5.44e-06	7.05e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.1e-06	6.61e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	5.09e-06	6.59e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.04e-06	6.52e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.99e-06	6.46e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	4.77e-06	6.18e-05	CbGpPWpGaD
